国泰君安(02611.HK)拟行使"16国君G3"发行人赎回选择权
格隆汇7月24日丨国泰君安(02611.HK)公告,关于行使2016年公司债券(第二期)品种一发行人赎回选择权的第三次提示性,公司于2016年8月12日发行完成16国君G3,2019年8月12日为16国君G3第3个计息年度付息日。
根据《募集说明书》有关条款的约定,公司可于第3个计息年度付息日前的第30个交易日,决定是否行使发行人赎回选择权。2019年7月1日,公司决定行使16国君G3发行人赎回选择权,对赎回登记日登记在册的16国君G3全部赎回。公司将根据相关业务规则,做好16国君G3赎回事宜的后续信息披露及息2兑付工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.